Animal models of systemic sclerosis: Prospects and limitations
- 8 July 2010
- journal article
- review article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 62 (10), 2831-2844
- https://doi.org/10.1002/art.27647
Abstract
No abstract availableThis publication has 104 references indexed in Scilit:
- Antagonistic Effect of the Matricellular Signaling Protein CCN3 on TGF-β- and Wnt-Mediated Fibrillinogenesis in Systemic Sclerosis and Marfan SyndromeJournal of Investigative Dermatology, 2010
- Mutations in Fibrillin-1 Cause Congenital Scleroderma: Stiff Skin SyndromeScience Translational Medicine, 2010
- Increased PDGFRα Activation Disrupts Connective Tissue Development and Drives Systemic FibrosisDevelopmental Cell, 2009
- Transcription Factor Fli1 Regulates Collagen Fibrillogenesis in Mouse SkinMolecular and Cellular Biology, 2009
- Pro- and anti-fibrotic effects of TGF- in sclerodermaRheumatology, 2008
- Decreased expression of caveolin 1 in patients with systemic sclerosis: Crucial role in the pathogenesis of tissue fibrosisArthritis & Rheumatism, 2008
- Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2/AP-1Proceedings of the National Academy of Sciences of the United States of America, 2008
- Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout miceThe Journal of Experimental Medicine, 2007
- Avian Models with Spontaneous Autoimmune DiseasesAdvances in Immunology, 2006
- Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted MiceScience, 2001